StockpollyBeta
Get App
Popularity #2,826
DRUG · NASDAQ · Biotechnology

Bright Minds Biosciences (DRUG)

Develops selective serotonin agonists for epilepsy, PWS, and neuropsychiatric disorders.

$57.66
vs last close−3.02 (−4.97%)

In millions of USD, except per-share figures · converted from CAD at the latest rate

In millionsQ4 FY23Sep 2023Q1 FY24Dec 2023Q2 FY24Mar 2024Q3 FY24Jun 2024Q4 FY24Sep 2024Q1 FY25Dec 2024Q2 FY25Mar 2025Q3 FY25Jun 2025Q4 FY25Sep 2025Q1 FY26Dec 2025Q2 FY26Mar 2026Q3 FY26Jun 2026
Cost of revenue000000000000
Gross profit000000000000
1100112245118
Research & development110001223497
000000001122
Selling & marketing000000000000
General & administrative000000000120
Other expenses—00000000000
Operating income−1−100−1−1−2−2−4−5−11−8
0000010−11047
Interest income000000000122
Interest expense000000000000
Other non-operating income00000−101−10−40
Income before tax−1−100−10−2−4−3−5−8−2
Net income from continuing operations−1−100−10−2−4−3−5−8−2
Net income−1−100−10−2−4−3−5−8−2
EPS, basic−$0.29−$0.31−$0.09$0.03−$0.12$0.01−$0.47−$0.52−$0.29−$0.69−$0.79−$0.18
EPS, diluted−$0.29−$0.31−$0.09$0.03−$0.12$0.01−$0.45−$0.52−$0.29−$0.69−$0.79−$0.18
Weighted average shares, basic44444447781010
Weighted average shares, diluted44455557781010
EBITDA0−100−10−2−4−3−5−8−8
Depreciation & amortization100000000000
EBIT−1−100−10−2−4−3−5−8−8